JE Jeng

604 total citations
14 papers, 523 citations indexed

About

JE Jeng is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, JE Jeng has authored 14 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 10 papers in Epidemiology and 4 papers in Oncology. Recurrent topics in JE Jeng's work include Liver Disease Diagnosis and Treatment (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Hepatitis B Virus Studies (5 papers). JE Jeng is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Hepatitis B Virus Studies (5 papers). JE Jeng collaborates with scholars based in Taiwan. JE Jeng's co-authors include ZY Lin, WY Chang, MY Hsieh, Zu‐Yau Lin, Jung‐Fa Tsai, Meng‐Hsuan Hsieh, Jung‐Fa Tsai, Wen‐Yu Chang, Lea‐Yea Chuang and Li‐Yeh Chuang and has published in prestigious journals such as Hepatology, British Journal of Cancer and Medicine.

In The Last Decade

JE Jeng

14 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JE Jeng Taiwan 12 338 312 129 108 69 14 523
ZY Lin Taiwan 8 270 0.8× 241 0.8× 71 0.6× 72 0.7× 28 0.4× 9 367
Jinlin Jia China 13 59 0.2× 96 0.3× 336 2.6× 59 0.5× 265 3.8× 19 533
Marzena Swiderska‐Syn United States 10 159 0.5× 160 0.5× 146 1.1× 52 0.5× 43 0.6× 15 387
Şahin Laçin Türkiye 10 50 0.1× 53 0.2× 69 0.5× 98 0.9× 37 0.5× 37 242
Guillaume Fallot France 8 291 0.9× 332 1.1× 154 1.2× 60 0.6× 72 1.0× 12 519
Yih-Jyh Lin Taiwan 14 162 0.5× 122 0.4× 149 1.2× 110 1.0× 104 1.5× 23 501
Toshiya Osawa Japan 9 215 0.6× 188 0.6× 74 0.6× 78 0.7× 42 0.6× 22 373
Sawako Uchida‐Kobayashi Japan 11 293 0.9× 262 0.8× 69 0.5× 99 0.9× 45 0.7× 59 474
M. Guidi Italy 10 310 0.9× 298 1.0× 74 0.6× 66 0.6× 31 0.4× 16 524
Ta‐Cheng Wei Taiwan 7 276 0.8× 207 0.7× 99 0.8× 91 0.8× 84 1.2× 11 484

Countries citing papers authored by JE Jeng

Since Specialization
Citations

This map shows the geographic impact of JE Jeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JE Jeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JE Jeng more than expected).

Fields of papers citing papers by JE Jeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JE Jeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JE Jeng. The network helps show where JE Jeng may publish in the future.

Co-authorship network of co-authors of JE Jeng

This figure shows the co-authorship network connecting the top 25 collaborators of JE Jeng. A scholar is included among the top collaborators of JE Jeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JE Jeng. JE Jeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Tsai, Jung‐Fa, JE Jeng, Lea‐Yea Chuang, et al.. (2005). Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma. Scandinavian Journal of Gastroenterology. 40(1). 68–75. 35 indexed citations
2.
Tsai, Jung‐Fa, JE Jeng, Li‐Yeh Chuang, et al.. (2003). Serum Insulin-Like Growth Factor-II and α-Fetoprotein as Tumor Markers of Hepatocellular Carcinoma. Tumor Biology. 24(6). 291–298. 30 indexed citations
3.
Tsai, Jung‐Fa, Li‐Yeh Chuang, JE Jeng, et al.. (2001). Betel quid chewing as a risk factor for hepatocellular carcinoma: a case–control study. British Journal of Cancer. 84(5). 709–713. 62 indexed citations
4.
Tsai, Jung‐Fa, JE Jeng, Lea‐Yea Chuang, et al.. (1997). Urinary Transforming Growth Factor-β1 in Relation to Serum α-Fetoprotein in Hepatocellular Carcinoma. Scandinavian Journal of Gastroenterology. 32(3). 254–260. 7 indexed citations
5.
Tsai, Jung‐Fa, Lea‐Yea Chuang, JE Jeng, et al.. (1997). Clinical Relevance of Transforming Growth Factor-beta 1 in the Urine of Patients with Hepatocellular Carcinoma. Medicine. 76(3). 213–226. 38 indexed citations
6.
Jeng, JE, et al.. (1997). Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma. British Journal of Cancer. 75(10). 1460–1466. 36 indexed citations
7.
Tsai, Jung‐Fa, JE Jeng, Lea‐Yea Chuang, & Wen‐Yu Chang. (1997). Urinary transforming growth factor β1 levels in hepatitis C virus-related chronic liver disease: Correlation between high levels and severity of disease. Hepatology. 25(5). 1141–1146. 20 indexed citations
8.
Jeng, JE, et al.. (1997). Elevated urinary transforming growth factor-β1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma. British Journal of Cancer. 76(2). 244–250. 45 indexed citations
9.
Jeng, JE, et al.. (1997). Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study. British Journal of Cancer. 76(7). 968–974. 115 indexed citations
10.
Jeng, JE, et al.. (1996). Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma. British Journal of Cancer. 73(12). 1498–1502. 42 indexed citations
11.
Jeng, JE, et al.. (1995). Clinical evaluation of serum α-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma. British Journal of Cancer. 72(2). 442–446. 22 indexed citations
12.
Jeng, JE, et al.. (1994). Antibodies to Hepatitis E and A Viruses among Patients with Non-Alcoholic Chronic Liver Disease in Taiwan. Scandinavian Journal of Gastroenterology. 29(7). 651–654. 5 indexed citations
13.
Tsai, Jung‐Fa, JE Jeng, Wen‐Yu Chang, Zu‐Yau Lin, & Jung‐Fa Tsai. (1994). Hepatitis C Virus Infection among Patients with Chronic Liver Disease in an Area Hyperendemic for Hepatitis B. Scandinavian Journal of Gastroenterology. 29(6). 550–552. 22 indexed citations
14.
Chang, WY, et al.. (1994). Frequency of raised α-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C. British Journal of Cancer. 69(6). 1157–1159. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026